Payden & Rygel’s Sanofi SNY Stock Holding History

Payden & Rygel’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-220	Closed	-$9K	–	129
2016 Q1	$9K	Hold	220	–	–	﹤0.01%	127
2015 Q4	$9K	Buy	+220	New	+$10.1K	﹤0.01%	191

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Payden & Rygel's SNY Position: Q2 2016 in Review

Payden & Rygel sold out of Sanofi (SNY) in Q2 2016, closing a stake of 220 shares — an estimated $9K sold.

Payden & Rygel first reported a position in SNY in Q4 2015 and held it in 2 quarters. The position peaked at $9K in Q1 2016. 449 funds tracked by Wall St. Rank hold SNY as of Q2 2016.

Payden & Rygel reported no remaining Sanofi position as of Q2 2016 after selling out during the quarter.
Payden & Rygel sold 220 Sanofi shares in Q2 2016, an estimated $9K.
Payden & Rygel first reported a position in Sanofi in Q4 2015 and held it in 2 quarters.
Payden & Rygel's Sanofi position peaked at $9K in Q1 2016.
449 funds tracked by Wall St. Rank held Sanofi as of Q2 2016.

Based on Payden & Rygel's 13F filing for Q2 2016, filed 5 Aug 2016.